This paid-for advertorial by CDD Vault appeared in the DDW / ELRIG UK Drug Discovery 2021 supplement in DDW Volume 22, Issue 4 – Fall 2021 For any research-based organisation in the life sciences arena, experimental data is the key to deriving biological and biochemical insight and understanding, and ultimately driving… Read More
This paid-for advertorial by Manchester BioGel appeared in the DDW / ELRIG UK Drug Discovery 2021 supplement in DDW Volume 22, Issue 4 – Fall 2021 Communication of cells with their microenvironment is vital in understanding intracellular processes. Most matrices lack the mechanical and biochemical tuneability necessary to recreate the cancer microenvironment. Read More
A new brochure by Sartorius is now available to download. Vaccination is the most effective method of preventing infectious diseases, and is considered one of the greatest achievements in medicine. Until today, various vaccines against several crucial diseases (including influenza, chicken pox, or HPV) have been developed that save… Read More
Vaccination is the most effective method of preventing infectious diseases, and is considered one of the greatest achievements in medicine. Until today, various vaccines against several crucial diseases (including influenza, chicken pox, or HPV) have been developed that save millions of lives. The continuous emergence of new diseases and… Read More
The Pistoia Alliance has announced plans to respond to the changing needs of the life science industry as digital transformation accelerates. The Alliance has hired Imran Haq, Anca Ciobanu and Linda Kasim to lead the three new themes of its reorganised project portfolio: Emerging Science and Technology,… Read More
Macrogen Europe has opened a new sequencing facility in Maastricht. It is located close to the Netherlands’ southern border, which, combined with a fast in-house sample pickup service, means that Macrogen Europe can now offer Sanger sequencing results within 24 hours of sample pickup throughout Belgium and the Netherlands. The… Read More
Swedish biotech company Salipro Biotech has entered into a collaboration and licensing agreement with AbCellera for access to its proprietary Salipro Platform, which stabilises challenging G protein coupled receptor (GPCR), ion channel and transporter antigens. “We are excited to build on the success of our previous studies and deepen our relationship with the team at AbCellera,”… Read More
Advances in treatments for human diseases, including cancer, rely on the ability to gain detailed information into the function, modulation, and variation of the immune system in response to stimuli or immunological challenge. Insights derived from these data have, for example, revolutionised cancer treatment by enabling the development of… Read More
PerkinElmer is expanding its Horizon Discovery CHOSOURCE platform to include a new expression cell line, CHO-K1 ADCC+, which may improve potency and efficacy of therapeutic antibodies and fusion protein biotherapeutics, as well as reduce dosage requirements and side effects for patients. This new expression host was built… Read More
Exscientia, the Medical University of Vienna and the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences has published final results from the EXALT-1 trial in Cancer Discovery. The study, titled “Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Haematological Cancers and Identifies Exceptional Responders,” illustrates the potential… Read More
BioIVT has added advanced tissue, biofluid and cell search and e-commerce capabilities to its website, which is enabling customers to mine its biospecimen repository and related clinical database using artificial intelligence (AI) and machine learning (ML) applications to advance scientific knowledge of different diseases. According to BioIVT, more than… Read More
CN Bio has launched an oncology service which it says is in response to the global need to improve cancer drug discovery approval rates. Understanding the relationship between pharmacokinetics, pharmacodynamics (PK/PD) and efficacy is critical to the successful development of new medicines, but at present this relationship is primarily investigated using… Read More
1910 Genetics has been awarded an approximate $550,000 Phase I STTR grant by the National Institutes of Health (NIH). The grant, received from the National Institute of Neurological Disorders and Stroke (NINDS) as part of the Helping to End Addiction Long-term Initiative, or NIH HEAL Initiative, supports… Read More
Brooks Automation and Cleveland Clinic have opened a 22,000-square-foot biospecimen sample management and repository facility on Cleveland Clinic’s main campus. The biorepository is managed by Azenta Life Sciences, Brooks’ recently re-branded life sciences division, and includes ultra-cold and cryogenic storage for researchers at Cleveland Clinic and other institutions. The… Read More
A team of medical and pharmaceutical experts has founded SynaptixBio, an Oxford-based research company working to develop the world’s first disease-modifying treatment for TUBB4a leukodystrophy, including H-ABC – a debilitating and potentially life-limiting condition. This is a sponsored research agreement with Children’s Hospital of Philadelphia (CHOP) in the US. Read More
The application of artificial intelligence (AI) in the drug discovery process is promising to drastically cut down timelines and costs of bringing new therapies to patients. The potential for AI to address these pain points has drawn significant attention from investors and players in the pharmaceutical industry. Typically, the development… Read More
